TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTCRYPTOMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTERTECHNOLOGY
Search

LATEST NEWS

Shire to Acquire Biopharma Company Baxalta in $32B Deal
VIDEO

Shire to Acquire Biopharma Company Baxalta in $32B Deal

Amicus Shares Barely Budge on Prediction of $3 Billion Buyout
STOCKS

The Nominees for Best Biopharma CEO of 2015 Are...

Today's Pre-Market Mover With Heavy Volume: Physicians Realty (DOC)
MARKETS

3 Drugs Stocks Moving The Industry Upward

Trade-Ideas: Marvell Technology Group (MRVL) Is Today's Post-Market Leader Stock
MARKETS

Dyax (DYAX) Moving On Heavy Volume In The Pre-Market Hours

OPEC Begins Meeting Today, Saudis May Cut Oil Production
VIDEO

OPEC Begins Meeting Today, Saudis May Cut Oil Production

Today's Weak On High Volume Stock: Primero Mining (PPP)
MARKETS

Trade-Ideas: Dyax (DYAX) Is Today's Post-Market Leader Stock

'Mad Money' Lightning Round: I Can't Wait to Buy More Starbucks
JIM CRAMER

'Mad Money' Lightning Round: Northrop Grumman, Lockheed Martin Both Terrific

Jim Cramer's 'Mad Money' Recap: Here's What I'm Watching Next Week
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: Winners Remain When Rates Rise

S&P 500 on Track for Record Close as Crude Closes Higher
MARKETS

Stock Futures Are Edging Lower

Jim Cramer's 'Mad Money' Recap: Here's What I'm Watching Next Week
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: Here's How You Make Money on Value

Closing Bell: HP Inc. Up on Hewlett-Packard Split; Stocks Rally
VIDEO

Closing Bell: HP Inc. Up on Hewlett-Packard Split; Stocks Rally

S&P 500 on Track for Record Close as Crude Closes Higher
MARKETS

Stocks Rally to Begin 'Pivotal' Week for Rates Outlook

Don't Tell Anyone: Insiders Are Buying These Stocks Like Crazy
MARKETS

Stocks Extend Gains as Health Care Leads

Facebook's Earnings Show Best Is Yet to Come: What Wall Street Is Saying
OPINION

4 Big Stocks on Traders' Radars: Buy, Sell or Hold?

Shire’s Shares Rise on FDA Approval of Dry Eye Med
MERGERS AND ACQUISITIONS

Drug Giant Shire Snaps Up Biotech Dyax for $5.9 Billion

Midday Report: Dyax Deal Boosts Health Care; Stocks Climb
VIDEO

Midday Report: Dyax Deal Boosts Health Care; Stocks Climb

Stocks Finish Higher as U.S. and China Meet for Crucial Trade Talks
MARKETS

Stocks Higher as Dyax Deal Boosts Health Care

PACCAR (PCAR) Stock Down Following Q4 Earnings
MARKETS

Dyax (DYAX) Stock Soars on $5.9 Billion Shire Deal

Stocks Finish Lower on Report U.S.-China Trade Pact May Be Delayed
MARKETS

Stock Futures Edge Higher, Asian Markets Slide

Today's Weak On High Volume Stock: Spirit AeroSystems Holdings (SPR)
MARKETS

Heavy Trading On Dyax (DYAX) Before Market Open

Galena Craters on Breast Cancer Vaccine Study Failure
STOCKS

Shire to Acquire Dyax for $5.9 Billion to Bolster Rare Disease Drug Business

Best and Worst Closed-End Funds
STOCKS

Nov. 2 Premarket Briefing: 10 Things You Should Know

Perilous Reversal Watch: Golar LNG (GLNG)
MARKETS

Barbarian At The Gate: Dyax (DYAX)

Analysts' Actions -- Amazon, CVS, Raytheon, Western Digital and More
STOCKS

Analysts' Actions -- Twitter, Oracle, Analog Devices, Eastman Chemical

Today's Weak On High Volume Stock: Spirit AeroSystems Holdings (SPR)
MARKETS

Dyax (DYAX) Highlighted As Today's Perilous Reversal Stock